Investing Profile

David Goeddel


Managing Partner at The Column Group, California
Photo of David Goeddel, Managing Partner at The Column Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
The Column Group Managing Partner
$100K - $5.0M
CompanyStageDateRound SizeTotal Raised
Hexagon Bio
Series BSep 2021$61M
Series ASep 2020$47M
Co-investors: Millie Ray (The Column Group), Jakob Loven (Nextech Invest), Dusan Perovic (Two Sigma Ventures), Alex Kolicich (8VC)
Exonics Therapeutics
Series ANov 2017$40M
Peloton Therapeutics
Series DSep 2016$52M
Co-investors: Jim Tananbaum (Foresite Capital)
NGM Biopharmaceuticals
Series DMar 2015$58M
Series BNov 2011$55M
Series ADec 2009$27M
Co-investors: Peter Svennilson (The Column Group)
Flexus Biosciences
Series BDec 2014$38M
Co-investors: Beth Seidenberg (Kleiner Perkins)
Nurix Therapeutics
Series BMay 2014$25M
Seed RoundMay 2012$3.1M
Co-investors: Michael Rome (Foresite Capital)
Series CJan 2014$14M
Series CJun 2012$33M
Series BJun 2010$24M
Co-investors: Carl Gordon (OrbiMed), Richard Ulevitch (5am Ventures)
Constellation Pharmaceuticals
Series CJan 2012$95M
Co-investors: Robert Tepper (Third Rock Ventures), Tony Evnin (Venrock), Brian Gallagher (Abingworth)